# Halobetasol Propionate

NDC: 45802-129
Generic name: Halobetasol Propionate
Labeler / Manufacturer: Padagis Israel Pharmaceuticals Ltd
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CREAM
Routes: TOPICAL
Marketing started: 20080804

FDA application: ANDA077123

## Active ingredients

- HALOBETASOL PROPIONATE: .5 mg/g

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"45802-129"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=45802-129
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=df26430c-8182-4d03-a254-06d913de4c95